Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00006346 · ClinicalTrials.gov registry record · NA

Stress Reduction in Older Women With Stage II, Stage III, or Stage IV Breast Cancer

A NA study of Breast Cancer and Psychosocial Effects of Cancer and Its Treatment, sponsored by Unity Health Toronto.

Completed
Registry status
NA
Development phase
3
Study locations

NCT00006346 is a NA study of Breast Cancer and Psychosocial Effects of Cancer and Its Treatment that has completed, run by Unity Health Toronto. The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00006346, a NA study of Breast Cancer and Psychosocial Effects of Cancer and Its Treatment, has completed, sponsored by Unity Health Toronto.

COMPLETED
Registry status
NA
Development phase
3
Study locations

Study Summary

RATIONALE: Transcendental meditation may be an effective way to decrease the amount of stress in older women with breast cancer. It is not yet known if transcendental meditation is more effective than basic breast cancer education in improving quality of life. PURPOSE: This randomized clinical trialstudies stress reduction in improvingquality of life in older women with stage II, stage III, or stage IV breast cancer.

Interventions

  • PROCEDURE quality-of-life assessment
  • PROCEDURE psychosocial assessment and care

Study Locations (3)

Illinois

  • St. Joseph Hospital - Chicago

Indiana

  • Hope Center - Terre Haute

Iowa

  • Maharishi International University - Fairfield

Trial Details

FieldValue
Start Date 2000-08
Est. Completion 2003-09
Phase NA

Sponsor

Unity Health Toronto

12 total trials

What the Registry Record Tells You About NCT00006346

The ClinicalTrials.gov registry entry for NCT00006346 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Unity Health Toronto, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which quality-of-life assessment is the first listed.

NCT00006346 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Illinois, Indiana, Iowa.

Frequently Asked Questions

What is clinical trial NCT00006346 about?

NCT00006346 is a clinical study titled "Stress Reduction in Older Women With Stage II, Stage III, or Stage IV Breast Cancer". RATIONALE: Transcendental meditation may be an effective way to decrease the amount of stress in older women with breast cancer. It is not yet known if transcendental meditation is more effective than basic breast cancer education in improving quality of life. PURPOSE: This randomized clinical tria...

What is the current status of trial NCT00006346?

This trial is currently completed. It is a NA study. The study started on 2000-08. Estimated completion is 2003-09.

What conditions does trial NCT00006346 study?

This clinical trial studies the following conditions: Breast Cancer, Psychosocial Effects of Cancer and Its Treatment.

What interventions are being tested in trial NCT00006346?

The interventions under investigation include: quality-of-life assessment (PROCEDURE), psychosocial assessment and care (PROCEDURE).

Who is sponsoring clinical trial NCT00006346?

This trial is sponsored by Unity Health Toronto, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00006346 being conducted?

This trial has 3 study locations across Illinois, Indiana, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.